These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37297013)

  • 1. Utility of Patient-Reported Symptom and Functional Outcomes to Indicate Recovery after First 90 Days of Radical Cystectomy: A Longitudinal Study.
    Wang XS; Bree KK; Navai N; Kamal M; Shen SE; Letona E; Cleeland CS; Shi Q; Gottumukkala V
    Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37297013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting.
    Kamal M; Navai N; Bree KK; Williams LA; Cleeland CS; Shen SE; Wang XS
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcomes after oncologic hepatic resection predict the risk of delayed readiness to return to intended oncologic therapy (RIOT).
    Wang XS; Shi Q; Shen SE; Letona E; Kamal M; Cleeland CS; Aloia T; Gottumukkala V
    Eur J Surg Oncol; 2024 Jul; 50(7):108396. PubMed ID: 38754314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical Cystectomy.
    Kukreja JB; Shi Q; Chang CM; Seif MA; Sterling BM; Chen TY; Creel KM; Kamat AM; Dinney CP; Navai N; Shah JB; Wang XS
    Surg Innov; 2018 Jun; 25(3):242-250. PubMed ID: 29557251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of physical function by subjective and objective methods in patients undergoing open gynecologic surgery.
    Wang XS; Kamal M; Chen TH; Shi Q; Garcia-Gonzalez A; Iniesta MD; Cleeland CS; Gottumukkala V; Meyer LA
    Gynecol Oncol; 2021 Apr; 161(1):83-88. PubMed ID: 33536127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory.
    Fagundes CP; Shi Q; Vaporciyan AA; Rice DC; Popat KU; Cleeland CS; Wang XS
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):613-9.e2. PubMed ID: 26088408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal perioperative patient-reported outcomes in open compared with minimally invasive hysterectomy.
    Huepenbecker SP; Iniesta MD; Wang XS; Cain KE; Zorrilla-Vaca A; Shen SE; Basabe MS; Suki T; Garcia Lopez JE; Mena GE; Lasala JD; Williams LA; Ramirez PT; Meyer LA
    Am J Obstet Gynecol; 2024 Feb; 230(2):241.e1-241.e18. PubMed ID: 37827271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a patient-reported outcome tool for assessing symptom burden during perioperative care in liver surgery: The MDASI-PeriOp-Hep.
    Wang XS; Shi Q; Williams LA; Lillemoe HA; Chen TY; Gottumukkala V; Garcia-Gonzalez A; Malveaux D; Kamal M; Cleeland CS; Aloia TA
    Eur J Oncol Nurs; 2021 Jun; 52():101959. PubMed ID: 33964632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
    Wang XS; Shi Q; Williams LA; Cleeland CS; Garcia-Gonzalez A; Chen TY; Shahid DR; Ramirez PT; Iniesta MD; Siverand AM; Meyer LA
    Gynecol Oncol; 2019 Mar; 152(3):492-500. PubMed ID: 30876494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients.
    Meyer LA; Nick AM; Shi Q; Wang XS; Williams L; Brock T; Iniesta MD; Rangel K; Lu KH; Ramirez PT
    Gynecol Oncol; 2015 Mar; 136(3):440-5. PubMed ID: 25647455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of a Patient-Reported Symptom and Functioning Assessment Tool for Geriatric Oncology Care in China.
    Xue D; Li P; Chen TH; Shi Q; Wang XS
    Value Health Reg Issues; 2022 May; 29():28-35. PubMed ID: 34801883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies.
    Wang XS; Srour SA; Whisenant M; Subbiah IM; Chen TH; Ponce D; Gonzalez AG; Kamal M; Mendoza T; Cleland CS; Kebriaei P; Neelapu SS; Rezvani K; Ahmed S; Shpall E
    Transplant Cell Ther; 2021 Nov; 27(11):930.e1-930.e10. PubMed ID: 34265479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer.
    Frees SK; Aning J; Black P; Struss W; Bell R; Chavez-Munoz C; Gleave M; So AI
    World J Urol; 2018 Feb; 36(2):215-220. PubMed ID: 29116394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.
    Rosenthal DI; Mendoza TR; Fuller CD; Hutcheson KA; Wang XS; Hanna EY; Lu C; Garden AS; Morrison WH; Cleeland CS; Gunn GB
    Cancer; 2014 Jul; 120(13):1975-84. PubMed ID: 24711162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer.
    Zhang T; Zheng YY; Yang ZR; Shi Q; Wang XS; Zhao J; Yang M; Wu CL; Wang GR
    BMC Womens Health; 2021 Jul; 21(1):276. PubMed ID: 34325677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobile Postoperative Symptom Intervention Tool and Biometric Monitoring After Radical Cystectomy: Pilot Study Evaluating Feasibility, Usability, and Potential Utility.
    Huelster HL; Zemp L; Turner K; Gonzalez BD; Jim H; Gore LR; Gilbert SM
    J Urol; 2023 Feb; 209(2):410-421. PubMed ID: 36350586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of symptoms and distress in patients and families following cystectomy for treatment of muscle invasive bladder cancer.
    Benner C; Greenberg M; Shepard N; Meng MV; Rabow MW
    J Urol; 2014 Apr; 191(4):937-42. PubMed ID: 24184369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nursing Implication of People Treated by Radical Cystectomy Postsurgery and Rehabilitation.
    Lauridsen SV
    Semin Oncol Nurs; 2021 Feb; 37(1):151110. PubMed ID: 33408048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Robot-Assisted and Open Radical Cystectomy in Recovery of Patient-Reported and Performance-Related Measures of Independence: A Secondary Analysis of a Randomized Clinical Trial.
    Venkatramani V; Reis IM; Gonzalgo ML; Castle EP; Woods ME; Svatek RS; Weizer AZ; Konety BR; Tollefson M; Krupski TL; Smith ND; Shabsigh A; Barocas DA; Quek ML; Dash A; Parekh DJ
    JAMA Netw Open; 2022 Feb; 5(2):e2148329. PubMed ID: 35171260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of enhanced recovery after surgery program on patient-reported outcomes and function recovery in patients undergoing liver resection for hepatocellular carcinoma.
    Ren QP; Luo YL; Xiao FM; Wen TF; Wu MH; Juan-Wan ; Xie ZR
    Medicine (Baltimore); 2020 May; 99(20):e20062. PubMed ID: 32443312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.